At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT (positron emission tomography/ computed tomography) system enabling both outstanding image quality and intelligent quantitation, helping physicians to deliver the best possible patient outcomes.

Continuing to expand its portfolio of endovascular solutions, Medtronic Inc. announced that two recently U.S. Food and Drug Administration (FDA) approved devices will be featured at the Society for Vascular Surgery’s 2014 Vascular Annual Meeting, taking place June 5-7 in Boston. 

Wolters Kluwer Health announced that Kettering Health Network has selected ProVation Order Sets, powered by UpToDate Decision Support, as its clinical content management system.

Among the collection of aspiring medical isotope production companies looking to build facilities in the United States, CoquĂ­ RadioPharmaceuticals Corp. is he only one using a design and production method already proven in the commercial markets. CoquĂ­ is planning on constructing and operating a dedicated medical isotope production facility.


June 5, 2014 — Fairview Health Services, Minneapolis, recently became the first U.S. healthcare facility to install the Symbia Intevo xSPECT system from Siemens Healthcare. The first ever xSPECT system, the Symbia Intevo fully integrates single-photon emission computed tomography (SPECT) and CT during image reconstruction, combining SPECT’s high sensitivity with the high specificity of CT and completely integrating data from the two modalities to generate high resolution and, for the first time, quantitative images.

June 5, 2014 — Mercator MedSystems is in the midst of its prospective, 300-patient, 30-site DANCE (Dexamethasone to the Adventitia to eNhance Clinical Efficacy) clinical trial to study a new therapeutic approach to treating peripheral artery disease (PAD). The trial enrolled its first patient in November 2013, and incorporates the use of Mercator Med Systems’ U.S. Food and Drug Administration (FDA)-cleared Micro-Infusion drug delivery system.

June 5, 2014 — Lumedx Corp. and Scientific Software Solutions Inc. (SSS), maker of PedCath congenital catheterization reporting software, announced they are partnering to create an innovative solution for congenital cardiac data and image management.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now